Corrigendum to 'Should treatment of low-level rifampicin mono-resistant tuberculosis be different?' [JCTUBE 23 (2021) 100241].

Gopie, F ACommiesie, Ede Lange, W C Mvan Soolingen, DVreden, S G Sde Vries, G2021-07-122021-07-122021-05-133404210410.1016/j.jctube.2021.100245http://hdl.handle.net/10029/625034en© 2021 The Author(s).Corrigendum to 'Should treatment of low-level rifampicin mono-resistant tuberculosis be different?' [JCTUBE 23 (2021) 100241].Article2405-5794J Clin Tubercul Other Mycobact Dis 2021; 24:100245